ADVANCED COURSES & SEMINARS
Chairs: M.S. Aapro, CH - E. Felip, ES
The European School of Oncology is pleased to announce the 5th edition of "ESO Lung Cancer Observatory: innovation and care in the next 12 months", which will be held during the ELCC 2018 European Lung Cancer Conference on April 13 in Geneva, chaired by Dr. M.S Aapro and Dr. E. Felip, ES. The scope of the session is to provide the participants with a take home message on what they can expect to happen in the prostate cancer field in the next 12 months.
The Observatory will be held during the
M.S. Aapro, Clinique de Genolier, Geneva, CH
C. Adams, Union for International Cancer Control (UICC), Geneva, CH
B. Besse, Institut Gustave Roussy, Paris, FR
H. de Koning, Erasmus University Rotterdam, NL
E. Felip, Vall d’Hebron University Hospital, Barcelona, ES
F. Johansson, Swedish Lung Cancer Association “Stodet”, Stockholm, SE
K. Kerr, Abardeen Royal Infirmary, Foresterhill, Abardeen, UK
F. Mornex, Centre Hospitalier Lyon Sud, FR
P. Van Schil, University Hospital of Antwerp, Edegem, BE
European School of Oncology
Via Turati 29
20121, Milan, Italy
30 Route François-Peyrot
1218 Le Grand-Saconnex
Attendance is granted to all participants registered to the ELCC 2018 European Lung Cancer Conference.
13 April 2018
16:45 - 18:15 (Palexpo, Room W)
Early-stage NSCLC, next steps: staging, surgery, molecular determinations
P. Van Schil, BE
Tobacco control, strategies and figures: what’s next?
C. Adams, CH
Lung cancer screening in 2019?
H. de Koning, NL
Radiation oncology: new approaches in 2019
F. Mornex, FR
What to ask your pathologist today and in 2019?
K. Kerr, UK
Developments immunotherapy: what practice changing studies will mature in 2019?
B. Besse, FR
Developments in targeted therapies: what practice changing studies will mature in 2019
E. Felip, ES
The patient’s perspective
F. Johansson, SE